A California appeals court, in reinstating the cancer suits Nov. 6, followed the lead of the U.S. Court of Appeals for the Ninth Circuit in an opinion issued last December.
The federal appeals court reversed a federal trial judge’s dismissal of hundreds of suits in consolidated litigation, ruling they were improperly barred by federal drug labeling law.
Similarly, the ...